Quantcast
Last updated on April 24, 2014 at 10:24 EDT

Latest Microarrays Stories

2013-11-07 16:31:43

Announces Record Revenue for the Quarter SAN DIEGO, Nov. 7, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today reported total revenues of $44.0 million for the third quarter of 2013, an increase of 26% compared to revenues of $34.9 million for the second quarter of 2013, and an increase of 92% compared to revenues of $22.9 million for the third quarter of 2012. "We are proud to report...

2013-11-05 16:26:36

DUBLIN, November 5, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/66tsj8/analysis_of) has announced the addition of the "Analysis of Global Biochips Industry, 2012-2018" [http://www.researchandmarkets.com/research/66tsj8/analysis_of ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Global biochips market is forecasted to reach US$11.4 billion by 2018 with a CAGR of 18.6% during...

2013-11-05 08:36:05

NEW BRUNSWICK, N.J., Nov. 5, 2013 PRNewswire/ -- The U.S. Department of Veterans Affairs has awarded a five-year contract for genotyping in support of its Million Veteran Program to the BioProcessing Solutions Alliance, which is a unique partnership between a research center at Rutgers, The State University of New Jersey, and a corporate provider of sample management solutions for the bioscience industry. Officials of RUCDR Infinite Biologics, the world's largest university-based...

2013-10-31 12:26:51

SAN JOSE, Calif., Oct. 31, 2013 /PRNewswire/ -- Ariosa Diagnostics, Inc., won summary judgment yesterday in a patent infringement litigation involving U.S. Patent No. 6,258,540 against Sequenom, Inc., an exclusive licensee of the patent from Isis Innovations, Inc. The United States District Court for the Northern District of California invalidated the '540 patent at issue, giving Ariosa a complete victory in the case. The patent at issue is related to the detection of fetal cell-free...

2013-10-30 23:23:15

The global market for biochips was valued at $3.3 billion in 2012 and is expected to increase to nearly $3.9 billion in 2013. BCC Research projects the market to reach $14.4 billion in 2018, and register a compound annual growth rate (CAGR) of 30% for the period 2013 to 2018. Wellesley, MA (PRWEB) October 30, 2013 According to a new technical market research report, Global Biochip Markets: Microarrays and Lab-on-a-Chip from BCC Research (http://www.bccresearch.com), the global market for...

2013-10-25 08:25:13

NEW YORK, October 25, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research "SNP Genotyping and Analysis Market (GeneChips, Taqman Allelic Discrimination, Pyrosequencing, AB SNPlex, Sequenom MassARRAY MALDI-TOF): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global SNP genotyping and analysis market was valued at USD 2,385.2 million in 2012 and is expected to grow at a CAGR of 21.8% from 2013 to...

2013-10-24 08:33:35

SAN DIEGO, Oct. 24, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the third quarter of 2013 after closing of the NASDAQ Global Market on Thursday, November 7, 2013. A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at 5:00 pm EST (2:00...

2013-10-22 08:32:06

The MaterniT21 PLUS Test Celebrates its Second Anniversary Since Launch SAN DIEGO, Oct. 22, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Center for Molecular Medicine, doing business as Sequenom Laboratories, has launched the Enhanced Sequencing Series for its MaterniT21(TM) PLUS laboratory-developed test (LDT). The MaterniT21 PLUS test...

2013-10-21 08:29:37

SUNNYVALE, Calif., Oct. 21, 2013 /PRNewswire/ -- ARRAYit Corporation (OTCQB: ARYC) announces that the company has shipped its proprietary microarray life sciences products to Illumina Inc. (NASDAQ: ILMN), a developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and biological function using its proprietary bead array and solid phase sequencing technologies to empower DNA microarray and next generation sequencing (NGS)...

2013-10-09 16:22:35

ReportsnReports.com offers Analysis of Global Biochips Industry, 2012-2018 market research report that reviews the latest biochips market trends with a perceptive attempt to disclose the near-future growth prospects. DALLAS, Oct. 9, 2013 /PRNewswire-iReach/ -- Analysis of Global Biochips Industry, 2012-2018 market research report forecasts the global biochips market to reach US$11.4 billion by 2018 with a CAGR of 18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific...